CJC-1295 No DAC (5mg): Mechanism, Research Profile, and Scientific Overview
CJC-1295 No DAC (also known as Modified GRF 1-29) is a synthetic growth hormone-releasing hormone (GHRH) analog widely studied in endocrinology and molecular biology research. It is designed to stimulate natural growth hormone (GH) release from the pituitary gland in a pulsatile pattern, closely mimicking the body’s physiological hormone rhythm.
In modern peptide research, CJC-1295 No DAC is frequently investigated for its role in growth hormone regulation, metabolic signaling, and recovery-related biological pathways.
What Is CJC-1295 No DAC?
CJC-1295 No DAC is a shortened-acting analog of GHRH (1–29 fragment) that has been modified to resist enzymatic breakdown, improving its stability compared to native GHRH.
Unlike the DAC version, the “No DAC” form does not bind to albumin, resulting in a shorter half-life (~30 minutes) and more natural GH pulsatility patterns. (Peptide Science Institute)
Researchers use this distinction to study how timing and amplitude of GH release affect downstream biological processes.
CJC-1295 No DAC vs DAC Version
The key difference between the two forms is pharmacokinetics:
- No DAC (Mod GRF 1-29): short-acting, pulsatile GH release
- DAC version: long-acting, sustained GH elevation due to albumin binding (Peptide.co)
This difference makes No DAC more suitable for research models focused on physiological hormone rhythms, while DAC is used in studies requiring prolonged exposure.
Mechanism of Action (Research Context)
CJC-1295 No DAC works by binding to growth hormone-releasing hormone receptors (GHRH-R) located in the anterior pituitary gland.
This interaction stimulates:
- Endogenous growth hormone secretion
- Downstream IGF-1 signaling pathways
- Pulsatile endocrine activity patterns
- Regulation of metabolic homeostasis
Because it does not directly replace hormones, it is often described as an upstream endocrine signaling modulator.
Molecular and Structural Features
CJC-1295 No DAC is a modified 29-amino-acid peptide derived from native GHRH.
Key structural modifications include:
- Amino acid substitutions to resist enzymatic breakdown
- Increased receptor binding stability
- Improved biological half-life compared to native GHRH
- Preservation of pulsatile signaling behavior
These modifications make it a widely used tool in peptide receptor research.
Research Applications
CJC-1295 No DAC is used in laboratory and preclinical research involving:
- Growth hormone axis regulation
- Endocrine signaling studies
- Metabolic rate and energy balance research
- Tissue repair and recovery models
- Aging biology and hormonal decline studies
- Neuroendocrine feedback system research
Synergy Research (CJC-1295 No DAC Combinations)
In research literature, CJC-1295 No DAC is often studied alongside growth hormone secretagogues such as ghrelin receptor agonists to evaluate combined effects on GH pulsatility and amplitude.
These studies examine:
- GH pulse frequency amplification
- Receptor pathway interaction
- Endocrine feedback modulation
- Recovery signaling pathways
Safety and Regulatory Status
CJC-1295 No DAC is not an approved therapeutic drug in most regulatory jurisdictions, including the United States and United Kingdom.
It is generally classified as a research-only compound, and scientific literature emphasizes that:
- Human safety data is limited
- Clinical outcomes are not fully established
- Purity and sourcing variability may exist in unregulated markets (The Washington Post)
Why Researchers Study CJC-1295 No DAC
Scientific interest continues because it provides a controlled model for studying:
- Natural GH secretion rhythms
- Pituitary responsiveness
- Endocrine feedback loops
- Metabolic adaptation mechanisms
- Hormonal aging processes
Its pulsatile profile makes it especially valuable in physiology-based endocrine research.
Conclusion
CJC-1295 No DAC (5mg) is a GHRH analog used in scientific research to explore growth hormone regulation, metabolic signaling, and endocrine system dynamics. Its short-acting, pulsatile mechanism distinguishes it from long-acting DAC versions and makes it a key compound in physiological hormone studies.
Ongoing research continues to investigate how modulation of the GH axis impacts metabolism, recovery, and age-related hormonal changes.
Reviews
There are no reviews yet.